Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Revenue (2020 - 2025)

iSpecimen has reported Revenue over the past 6 years, most recently at $51761.0 for Q4 2025.

  • Quarterly results put Revenue at $51761.0 for Q4 2025, down 96.49% from a year ago — trailing twelve months through Dec 2025 was $1.9 million (down 79.24% YoY), and the annual figure for FY2025 was $1.9 million, down 79.24%.
  • Revenue for Q4 2025 was $51761.0 at iSpecimen, down from $106592.0 in the prior quarter.
  • Over the last five years, Revenue for ISPC hit a ceiling of $3.0 million in Q1 2021 and a floor of $51761.0 in Q4 2025.
  • Median Revenue over the past 5 years was $2.6 million (2021), compared with a mean of $2.1 million.
  • Biggest five-year swings in Revenue: surged 93.0% in 2021 and later plummeted 96.49% in 2025.
  • iSpecimen's Revenue stood at $2.5 million in 2021, then increased by 16.18% to $3.0 million in 2022, then decreased by 13.05% to $2.6 million in 2023, then crashed by 42.7% to $1.5 million in 2024, then plummeted by 96.49% to $51761.0 in 2025.
  • The last three reported values for Revenue were $51761.0 (Q4 2025), $106592.0 (Q3 2025), and $713135.0 (Q2 2025) per Business Quant data.